January 2004
Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
Dec   Feb


For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.


C H A N N E L S
• PULSE Home Page
• EXECUTIVE EDITION

• US News
• Canada News
• UK News
• New Zealand News

• Consumer Advocacy
• Health Care Systems
• Managed Care/Medicaid
• Co-occurring Disorders
• Clinical studies
• Pharmaceutical News
• Criminal Justice Systems
• Legislative News


U S E R ' S   G U I D E
About PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE


E M A I L   S U B S C R I P T I O N S

For WEEKLY summaries of PULSE postings, see the weekly email subscription form.

For DAILY mailings (powered by Bloglet), please enter your e-mail address below:


P U B L I C A T I O N S

PULSE ANNUAL No. 2
January 2003

Recent Trends, Challenges and Issues in Funding Public Mental Health Services in the US
March 2002

PULSE ANNUAL No. 1
October 2001

 

PULSE is powered by
Radio Userland.

Listed on BlogShares

© Bill Davis, 2000-2003.

About PULSE | Channels | User's Guide | Email subscriptions | Publications




PULSE is a free service of the Centre for Community Change International, gathering new and noteworthy Internet resources for mental health providers, family members of individuals with mental illness, consumers of mental health services and consumer advocates. PULSE is researched, edited and designed by Bill Davis.



daily link  Thursday, January 22, 2004


Hormonal Treatments for Women With Schizophrenia
Article in the latest Psychiatric Times - "Women with schizophrenia may benefit from hormone replacement therapy. A new study measured the efficacy of estrogen, progesterone, Prolactin, luteinizing hormone, follicle stimulating hormone and testosterone on women with the disorder.."  
permalink  

Hormones for Perimenopausal and Postmenopausal Depression
Article in the latest Psychiatric Times - "Estrogen and progesterone are believed to play a role in the regulation of mood and well-being. Several mechanisms have been proposed for this effect, including the hormones' influence on monoamine oxidase (MAO) metabolism. Estrogen inhibits MAO, thereby diminishing the degradation of norepinephrine and serotonin and thus increasing their activity, while progesterone has the reverse impact on MAO (Chakravorty and Halbreich, 1997; Luine and Rhodes, 1983). Allopregnanolone, a metabolite of progesterone, is a potent neuroactive steroid that modulates g-aminobutyric acid (GABA) receptors and may be anxiolytic (Majewska et al., 1986). "  
permalink  

Nation's Health Plans Now Judged on Quality Standards for Treatment of Alcoholism
Press release from Ensuring Solutions to Alcohol Problems (George Washington University), reprinted at Join Together - "A tool that 90% of the nation's health plans already use to assess their performance in treating asthma, diabetes, and high blood pressure now includes new measures for how well plans do in treating patients who have been diagnosed with alcoholism and other drug disorders. According to a report released today by Ensuring Solutions to Alcohol Problems, holding plans accountable for timely and effective alcohol treatment should lead to improved service delivery and more informed health care contract negotiations. The new primer, Using Performance Measurement to Improve the Quality of Addiction Treatment, focuses on the inclusion of leading addiction treatment indicators in a popular performance measurement tool called the Health Plan Employer Data and Information Set (HEDIS) as part of a broader explanation of how both the private and public sectors are using performance measurement to demand greater accountability from health care providers. " See also the primer Using Performance Measurement to Improve the Quality of Addiction Treatment.  
permalink